These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37173655)

  • 1. Establishing minimal clinically important differences for the Quality of Life Instrument of Chronic Gastritis QLICD-CG(V2.0) based on distribution-based methods.
    Wu X; Chen Y; Wan C; Yu L; Lei P; Sun X
    BMC Gastroenterol; 2023 May; 23(1):149. PubMed ID: 37173655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of quality of life instruments for chronic diseases-Chronic gastritis version 2 (QLICD-CG V2.0).
    Quan P; Yu L; Yang Z; Lei P; Wan C; Chen Y
    PLoS One; 2018; 13(11):e0206280. PubMed ID: 30427879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing Minimal Clinically Important Differences for the Quality of Life Instrument in Patients With Breast Cancer QLICP-BR (V2.0) Based on Anchor-Based and Distribution-Based Methods.
    Li F; Liu Y; Wan C; Zhou J; Tan J; Chen H
    Front Oncol; 2022; 12():753729. PubMed ID: 35586490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of the Chronic Gastritis Scale Under the System of Quality of Life Instruments for Chronic Diseases QLICD-CG Based on Classical Test Theory and Generalizability Theory.
    Wan C; Chen Y; Gao L; Zhang Q; Li W; Quan P
    J Clin Gastroenterol; 2022 Feb; 56(2):e137-e144. PubMed ID: 33852446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the methods of establishing the minimum clinical important difference based on anchor and its application in the quality of life measurement scale QLICP-ES (V2.0) for esophageal cancer.
    Ren D; Wu T; Wan C; Li G; Qi Y; Fang Y; Zhong J
    Health Qual Life Outcomes; 2021 Jul; 19(1):173. PubMed ID: 34215267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the psoriasis scale among the system of quality of life instruments for chronic diseases QLICD-PS (V2.0).
    Liu Q; Feng L; Wan C; Tan J; Yu J; Wang L
    Health Qual Life Outcomes; 2022 Apr; 20(1):68. PubMed ID: 35459208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer.
    Zhou X; Liu Y; Tan J; Hu L; Chen H; Wan C
    Front Oncol; 2023; 13():1123258. PubMed ID: 37051543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and assessment of the Quality of Life Instruments for Chronic Diseases-Gout (QLICD-GO) (V2.0).
    Liu Q; Liu X; Zhang P; Xie X; Wan C; Wang X; Pan H
    Clin Rheumatol; 2023 Feb; 42(2):501-509. PubMed ID: 36414865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the osteoporosis scale among the system of quality of life instruments for chronic diseases QLICD-OS (V2.0).
    Liu Q; Li L; Ma W; Yang Z; Zhao R; Liu C; Wan C
    BMC Geriatr; 2024 May; 24(1):407. PubMed ID: 38714958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
    Ogura K; Yakoub MA; Christ AB; Fujiwara T; Nikolic Z; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2020 Sep; 478(9):2148-2158. PubMed ID: 32568896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the Minimal Clinically Important Difference for the PROMIS Upper Extremity Computer Adaptive Test Version 2.0 in a Nonshoulder Hand and Upper Extremity Population.
    Kazmers NH; Qiu Y; Yoo M; Stephens AR; Zeidan M; Zhang Y
    J Hand Surg Am; 2021 Oct; 46(10):927.e1-927.e10. PubMed ID: 33812773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Are the MCIDs for PROMIS, NDI, and ODI Instruments Among Patients With Spinal Conditions?
    Hung M; Saltzman CL; Kendall R; Bounsanga J; Voss MW; Lawrence B; Spiker R; Brodke D
    Clin Orthop Relat Res; 2018 Oct; 476(10):2027-2036. PubMed ID: 30179950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the Minimum Clinically Important Difference for the WOMAC Index After TKA?
    Clement ND; Bardgett M; Weir D; Holland J; Gerrand C; Deehan DJ
    Clin Orthop Relat Res; 2018 Oct; 476(10):2005-2014. PubMed ID: 30179956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Are the Minimal and Substantial Improvements in the HOOS and KOOS and JR Versions After Total Joint Replacement?
    Lyman S; Lee YY; McLawhorn AS; Islam W; MacLean CH
    Clin Orthop Relat Res; 2018 Dec; 476(12):2432-2441. PubMed ID: 30179951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.
    Bae E; Choi SE; Lee H; Shin G; Kang D
    BMC Pulm Med; 2020 Mar; 20(1):73. PubMed ID: 32293387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal clinically important difference of the King's Parkinson's disease Pain Scale.
    Taghizadeh G; Fereshtehnejad SM; Goudarzi S; Jamali S; Mehdizadeh M
    Disabil Rehabil; 2023 May; 45(10):1680-1683. PubMed ID: 35549801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal Clinically Important Differences for American Orthopaedic Foot & Ankle Society Score in Hallux Valgus Surgery.
    Chan HY; Chen JY; Zainul-Abidin S; Ying H; Koo K; Rikhraj IS
    Foot Ankle Int; 2017 May; 38(5):551-557. PubMed ID: 28193121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the minimum clinically important difference for grade I degenerative lumbar spondylolisthesis: insights from the Quality Outcomes Database.
    Asher AL; Kerezoudis P; Mummaneni PV; Bisson EF; Glassman SD; Foley KT; Slotkin JR; Potts EA; Shaffrey ME; Shaffrey CI; Coric D; Knightly JJ; Park P; Fu KM; Devin CJ; Archer KR; Chotai S; Chan AK; Virk MS; Bydon M
    Neurosurg Focus; 2018 Jan; 44(1):E2. PubMed ID: 29290132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.